Furthermore, in support of that assumption, another study indicated that non-steroidal anti-inflammatory drug application reduced the systemic inflammation and risk of CRC [ 30 ], suggesting that systemic inflammation is extremely significant in CRC development.
← all excerpts
Mean platelet volume/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study.
1
—
—